A detailed history of Invesco Ltd. transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,189 shares of ABOS stock, worth $43,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,189
Previous 18,986 4.2%
Holding current value
$43,107
Previous $45,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.22 - $3.54 $1,769 - $2,821
-797 Reduced 4.2%
18,189 $45,000
Q2 2024

Aug 13, 2024

BUY
$2.14 - $4.01 $40,630 - $76,133
18,986 New
18,986 $45,000

Others Institutions Holding ABOS

About Acumen Pharmaceuticals, Inc.


  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $96M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.